Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 55% ± 23% | |
| GABAergic neuron | 9 studies | 47% ± 24% | |
| amacrine cell | 8 studies | 44% ± 11% | |
| retinal cone cell | 8 studies | 57% ± 13% | |
| retinal rod cell | 8 studies | 42% ± 11% | |
| retinal ganglion cell | 7 studies | 58% ± 20% | |
| neuron | 6 studies | 37% ± 13% | |
| interneuron | 6 studies | 48% ± 19% | |
| retina horizontal cell | 6 studies | 43% ± 10% | |
| retinal bipolar neuron | 5 studies | 28% ± 7% | |
| granule cell | 4 studies | 42% ± 9% | |
| OFF-bipolar cell | 4 studies | 37% ± 22% | |
| ON-bipolar cell | 4 studies | 41% ± 20% | |
| GABAergic interneuron | 3 studies | 46% ± 4% | |
| GABAergic amacrine cell | 3 studies | 45% ± 17% | |
| glycinergic amacrine cell | 3 studies | 43% ± 13% | |
| rod bipolar cell | 3 studies | 41% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 2793.69 | 257 / 258 | 100% | 37.12 | 229 / 230 |
| brain | 96% | 8805.29 | 2534 / 2642 | 87% | 14.29 | 612 / 705 |
| uterus | 97% | 1355.60 | 165 / 170 | 67% | 6.98 | 308 / 459 |
| skin | 77% | 511.03 | 1398 / 1809 | 49% | 3.66 | 231 / 472 |
| esophagus | 53% | 597.07 | 760 / 1445 | 57% | 5.08 | 105 / 183 |
| ovary | 87% | 1026.65 | 157 / 180 | 20% | 1.00 | 88 / 430 |
| eye | 0% | 0 | 0 / 0 | 99% | 9.80 | 79 / 80 |
| thymus | 45% | 250.60 | 296 / 653 | 53% | 2.15 | 318 / 605 |
| prostate | 84% | 669.70 | 205 / 245 | 13% | 0.46 | 67 / 502 |
| breast | 46% | 277.16 | 212 / 459 | 48% | 2.45 | 538 / 1118 |
| bladder | 33% | 164.33 | 7 / 21 | 57% | 5.43 | 286 / 504 |
| pancreas | 10% | 53.57 | 32 / 328 | 79% | 4.73 | 140 / 178 |
| heart | 79% | 878.31 | 679 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 4.30 | 27 / 45 |
| lung | 6% | 36.25 | 34 / 578 | 52% | 3.78 | 603 / 1155 |
| intestine | 30% | 156.27 | 287 / 966 | 17% | 1.03 | 91 / 527 |
| adipose | 43% | 265.66 | 513 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 12% | 87.88 | 11 / 89 | 29% | 2.99 | 257 / 901 |
| stomach | 12% | 62.66 | 43 / 359 | 18% | 0.80 | 52 / 286 |
| blood vessel | 26% | 153.59 | 352 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 18% | 2.28 | 72 / 406 |
| spleen | 3% | 15.69 | 7 / 241 | 0% | 0 | 0 / 0 |
| muscle | 0% | 1.08 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005634 | Cellular component | nucleus |
| GO_0003729 | Molecular function | mRNA binding |
| Gene name | SRRM3 |
| Protein name | Serine/arginine repetitive matrix protein 3 Serine/arginine repetitive matrix 3 |
| Synonyms | |
| Description | FUNCTION: May play a role in regulating breast cancer cell invasiveness . May be involved in RYBP-mediated breast cancer progression . . |
| Accessions | A6NNA2 A0A087X0W5 ENST00000464752.1 ENST00000611745.2 A0A087WXA3 |